| Product: | Carmofur | ||||||
|---|---|---|---|---|---|---|---|
| Catalog Number: | 17410 | ||||||
| CAS Number: | 61422-45-5 | ||||||
| Synonyms: | HCFU; 1-Hexylcarbamoyl-5-flurouracil | ||||||
| Pricing: |
| ||||||
| Formula: | C11H16FN3O3 | ||||||
| Chemical Purity: | >98% | ||||||
| Molecular Weight: | 257.26 | ||||||
| Structure: |  | ||||||
| Appearance: | Solid | ||||||
| Category: | Anti-cancer compounds | ||||||
| Stability: | Stable under recommended storage conditions. | ||||||
| Storage: | Keep container tightly closed in a dry and well-ventilated place. Recommended storage temperature: 2-8°C | ||||||
| Transportation: | IATA: Hazard Class: 6.1; UN Number: UN2811; Packing Group: I; Shipping Name: Toxic solids, organic, n.o.s. (CARMOFUR) | ||||||
| Literature References: | Miyazaki, N., Tabata, Y., Anti-tumor activity of carmofur water-solubilized by lactic acid oligomer-grafted pullulan nanogels J. Nanosci. Nanotechnol. 9, 4797-4804, (2009); Baehring, J.M., Fulbright, R.K., Delayed leukoencephalopathy with stroke-like presentation in chemotherapy recipients J. Neurol. Neurosurg. Psychiatr. 79, 535-539, (2008); Watanabe, M., et al., Randomized trial of the efficacy of adjuvant chemotherapy for colon cancer with combination therapy incorporating the oral pyrimidine 1-hexylcarbamoyl-5-fluorouracil Langenbeck"s Arch. Surg. 391, 330-337, (2006) | ||||||
| MSDS: | |||||||
| Description: | Carmofur is a derivative of fluorouracil, an antimetabolite used as an antineoplastic agent. |
